Amgen (AMGN) to Release Quarterly Earnings on Tuesday
Amgen (NASDAQ:AMGN) is set to announce its earnings results on Tuesday, January 28th. Persons that are interested in participating in the company’s earnings conference call can do so using this link.
Shares of Amgen (NASDAQ:AMGN) opened at 119.29 on Monday. Amgen has a 52-week low of $82.82 and a 52-week high of $124.46. The stock’s 50-day moving average is $115.6 and its 200-day moving average is $112.4. The company has a market cap of $89.960 billion and a P/E ratio of 19.61.
The company also recently announced a quarterly dividend, which is scheduled for Friday, March 7th. Stockholders of record on Thursday, February 13th will be paid a dividend of 0.61 per share. This represents a $2.44 annualized dividend and a dividend yield of 2.05%. The ex-dividend date is Tuesday, February 11th. This is a boost from Amgen’s previous quarterly dividend of $0.47.
A number of research firms have recently commented on AMGN. Analysts at TheStreet reiterated a “buy” rating on shares of Amgen in a research note to investors on Tuesday, January 14th. On a related note, analysts at Nomura initiated coverage on shares of Amgen in a research note to investors on Wednesday, January 8th. They set a “neutral” rating and a $131.00 price target on the stock. Finally, analysts at Zacks reiterated a “neutral” rating on shares of Amgen in a research note to investors on Monday, December 30th. They now have a $121.00 price target on the stock. Nine investment analysts have rated the stock with a hold rating, fifteen have issued a buy rating and one has given a strong buy rating to the stock. The company presently has an average rating of “Buy” and an average target price of $123.04.
Amgen Inc is a global biotechnology pioneer that discovers, develops, manufactures and delivers human therapeutics.
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.